ProCE Banner Activity

Long-Acting Antiretroviral Therapy at CROI 2023: Here to Stay and, Perhaps, Just Beginning

Clinical Thought

Here is my take on important studies on LA ART presented at CROI 2023, with possible future implications for your practice.

Released: March 07, 2023

Expiration: March 05, 2024

Share

Faculty

Joseph J. Eron, Jr.

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Disclosure

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, Merck, ViiV; researcher: Gilead Sciences, ViiV.